Endometriosis
In the presence of an imbalance in the vaginal microbiota, a decrease or absence of certain specific bacteria (Atopobium, Gemella), combined with the overgrowth of Gardnerella, helps identify risk indicators for endometriosis from the onset of the first dysmenorrhea, prior to the detection of salivary microRNA biomarkers through genomic analysis.
This approach represents a significant advance in the early screening of endometriosis. Traditionally, diagnosis of this condition is made with an average delay of 7 to 10 years after the onset of the first symptoms. Analysis of the vaginal microbiota now offers a much faster detection opportunity, allowing for earlier therapeutic management. This non-invasive method, which can be performed as early as adolescence at the time of the first painful periods, could help prevent disease progression and significantly improve patients’ quality of life. In addition, this microbiota-based approach is a first-line test that is less costly and more accessible than complex genomic analyses, making large-scale screening easier.
This approach represents a significant advance in the early screening of endometriosis. Traditionally, diagnosis of this condition is made with an average delay of 7 to 10 years after the onset of the first symptoms. Analysis of the vaginal microbiota now offers a much faster detection opportunity, allowing for earlier therapeutic management. This non-invasive method, which can be performed as early as adolescence at the time of the first painful periods, could help prevent disease progression and significantly improve patients’ quality of life. In addition, this microbiota-based approach is a first-line test that is less costly and more accessible than complex genomic analyses, making large-scale screening easier.
Your sample is analyzed by a French medical laboratory accredited by COFRAC, with results certified by a medical biologist.
